Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chularat Hospital PCLBKK:CHG-R -7.03%81 EV-to-Revenue is 1.94 as of Sep. 01, 2026, which is 60% below its 10-year median of 4.86. GuruFocus rates BKK:CHG-R with a GF Score™ of 81/100 and a GF Value™ of ฿1.97 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 673 Healthcare Providers & Services companies, Chularat Hospital PCL ranks worse than 50.22% on this metric.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Chularat Hospital PCL's enterprise value is ฿16,485 Mil.
Chularat Hospital PCL's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 was ฿8,477 Mil. Therefore, Chularat Hospital PCL's EV-to-Revenue for today is 1.94.
The historical rank and industry rank for Chularat Hospital PCL's EV-to-Revenue or its related term are showing as below:
BKK:CHG-R'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.68 Med: 4.86 Max: 9.21
Current: 1.94
During the past 13 years, the highest EV-to-Revenue of Chularat Hospital PCL was 9.21. The lowest was 1.68. And the median was 4.86.
BKK:CHG-R's EV-to-Revenue is ranked worse than 50.22% of 673
companies
in the Healthcare Providers & Services industry
Industry Median: 1.83
vs BKK:CHG-R: 1.94
Chularat Hospital PCL's share price for today is ฿1.45035.
Chularat Hospital PCL's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.77.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chularat Hospital PCL EV-to-Revenue Related Terms
Chularat Hospital PCL EV-to-Revenue Historical Data
* Premium members only.
The historical data trend for Chularat Hospital PCL's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:CHG-R vs HCA, THC, EHC: EV-to-Revenue Comparison
For the Medical Care Facilities subindustry, Chularat Hospital PCL's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chularat Hospital PCL EV-to-Revenue vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Chularat Hospital PCL's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Chularat Hospital PCL's EV-to-Revenue falls into.
Chularat Hospital PCL's current Enterprise Value is ฿16,485 Mil.
Chularat Hospital PCL's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿8,477 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chularat Hospital PCL (BKK:CHG-R) has a EV-to-Revenue of 1.94 as of Sep. 01, 2026. EV to Revenue ratio is the company's enterprise value divided by sales. View historical data on Chularat Hospital PCL and its competitors. This is 60% below median its historical median of 4.86. Over the past decade, Chularat Hospital PCL's EV-to-Revenue has ranged from 1.68 to 9.21. According to the industry distribution chart, Chularat Hospital PCL ranks #338 out of 673 companies in the Healthcare Providers & Services industry, placing it in the top 50.2%.
Is Chularat Hospital PCL's EV-to-Revenue too high?
Chularat Hospital PCL's current EV-to-Revenue of 1.94 is 60% below median its 10-year median of 4.86. Over the past 10 years, this metric has ranged from a low of 1.68 to a high of 9.21. The Healthcare Providers & Services industry median EV-to-Revenue is 1.83. Chularat Hospital PCL's value of 1.94 is 6% above this industry median. Based on the distribution chart, Chularat Hospital PCL ranks #338 out of 673 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Chularat Hospital PCL has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chularat Hospital PCL's EV-to-Revenue compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Chularat Hospital PCL ranks #338 out of 673 companies for EV-to-Revenue. This places Chularat Hospital PCL in the lower half of its industry. The industry median EV-to-Revenue is 1.83. Chularat Hospital PCL's value of 1.94 is 6% above this benchmark. Historically, Chularat Hospital PCL's own EV-to-Revenue has ranged from 1.68 to 9.21 over the past decade. While the company's 10-year median is 4.86 vs. the industry median of 1.83, Chularat Hospital PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-Revenue for a Healthcare Providers & Services company?
The median EV-to-Revenue among Healthcare Providers & Services companies is 1.83, based on 673 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-Revenue significantly above this median, while those in the bottom quartile fall well below. However, EV-to-Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chularat Hospital PCL's current EV-to-Revenue of 1.94 is 6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-Revenue mean?
A high EV-to-Revenue can signal that a stock is expensive relative to its fundamentals. EV to Revenue ratio is the company's enterprise value divided by sales. View historical data on Chularat Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median EV-to-Revenue is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chularat Hospital PCL's current EV-to-Revenue is 1.94, which is 60% below median its own 10-year median of 4.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chularat Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, Chularat Hospital PCL (BKK:CHG-R) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿1.97, compared to a current price of ฿1.45 — trading 26.4% below its estimated fair value. The current EV-to-Revenue is 1.94, which is 60% below median its 10-year median of 4.86 and 6% above the Healthcare Providers & Services industry median of 1.83. Chularat Hospital PCL's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-Revenue calculated?
EV-to-Revenue is calculated from a company's financial statements. For Chularat Hospital PCL (BKK:CHG-R), the current EV-to-Revenue is 1.94 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chularat Hospital PCL (BKK:CHG-R) Overvalued in 2026?
Based on GuruFocus' analysis, Chularat Hospital PCL stock appears to be undervalued.
The current stock price of ฿1.45 is trading 26.4% below its estimated GF Value™ of ฿1.97.
GuruFocus considers Chularat Hospital PCL to be Modestly Undervalued.
Key valuation signals for BKK:CHG-R:
EV-to-Revenue: 1.94 (60% below median its 10-year median of 4.86)
GF Value™: ฿1.97 vs. price of ฿1.45 (26.4% below fair value)
Industry Position: 6% above the Healthcare Providers & Services median (#338 of 673)
No single metric tells the full story. See the BKK:CHG-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chularat Hospital PCL operates hospitals and clinics in Thailand. The company operates through several branches of clinics and hospitals. The Group operates a private hospital business which is one business segment. It has only one geographical segment as the business operates only in Thailand.
81GF Score
Get the complete analysis for BKK:CHG-R
EV-to-Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:CHG-R has been successfully added to your 
